Related Experiment Video
Updated: Aug 6, 2026
06:51
Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
CAR-T cell signaling dynamics, rational design principles and artificial intelligence for next-generation chimeric
Xin Liu1, Fangjia Tong2, Jiayi Zhang1
1Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
Frontiers in Immunology
|July 23, 2026
Summary
Chimeric antigen receptor (CAR) T cell therapy needs optimized signaling for solid tumors. Fine-tuning CAR signaling balances potency and durability, improving persistence and reducing toxicity for better cancer treatment.
Area of Science:
- Immunology
- Biotechnology
- Cancer Research
Background:
- Chimeric antigen receptor (CAR) T cell therapy shows promise in hematologic cancers but faces limitations in solid tumors.
- CAR signaling initiation, amplification, and regulation are critical challenges impacting efficacy and durability.
- CARs are synthetic receptors with signaling output dependent on their modular components and organization.
Purpose of the Study:
- To review advances in CAR signaling biology.
- To focus on temporal signaling thresholds and modular design principles.
- To discuss strategies for precise control of CAR signal strength and quality.
Main Methods:
- Literature review of recent advances in CAR signaling.
- Analysis of CAR design principles and their impact on signaling.
- Discussion of emerging strategies for signal modulation.
Main Results:
- CAR signaling requirements are dynamic, with insufficient or excessive signaling leading to impaired efficacy or exhaustion.
- A "less-is-more" approach in CAR design aims to balance potency with durability.
- Fine-tuning signal strength and quality is crucial for improved CAR T cell function.
Conclusions:
- Optimizing CAR signaling is key to enhancing efficacy in solid tumors and improving treatment durability.
- Future CAR designs may leverage high-throughput screening, computational modeling, and machine learning for personalized approaches.
- Precise control over CAR signal dynamics holds the potential for next-generation immunotherapies.
